Nelly Friedrichsen

Medicine & Life Sciences

1. 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole 52%
2. Alzheimer Disease 100%
3. Amyloid 75%
4. Amyloid Plaques 13%
5. Apolipoprotein E4 8%
6. Apolipoproteins E 6%
7. Atrophy 22%
8. Biomarkers 28%
9. Brain 14%
10. Cerebral Amyloid Angiopathy 17%
11. Cerebrospinal Fluid 15%
12. Cheirogaleidae 13%
13. Choroid Plexus 7%
14. Clinical Trials 7%
15. Cluster Analysis 5%
16. Cognition 6%
17. Cognitive Dysfunction 15%
18. Cross-Sectional Studies 13%
19. Dementia 14%
20. Disease Progression 9%
21. Down Syndrome 6%
22. florbetapir 21%
23. gantenerumab 31%
24. Hoarding 9%
25. Immunization 5%
26. Intermediate Filaments 6%
27. Internal Carotid Artery 6%
28. Lemur 5%
29. Longitudinal Studies 10%
30. Machine Learning 6%
31. Magnetic Resonance Imaging 6%
32. Mental Status and Dementia Tests 7%
33. Mutation 21%
34. Neuroimaging 8%
35. Observational Studies 10%
36. Parietal Lobe 8%
37. Parkinsonian Disorders 6%
38. Pathology 5%
39. Phase III Clinical Trials 7%
40. Phosphorylation 8%
41. Positron-Emission Tomography 27%
42. Presenilin-1 8%
43. Primates 7%
44. solanezumab 23%
45. Spastic Paraparesis 8%
46. Streptozocin 6%
47. Temporal Lobe 6%
48. White Matter 28%
49. Wounds and Injuries 5%